Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Net Cash Flow (2020 - 2025)

Caribou Biosciences has reported Net Cash Flow over the past 6 years, most recently at $1.2 million for Q4 2025.

  • Quarterly Net Cash Flow rose 107.96% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.9 million through Dec 2025, up 88.72% year-over-year, with the annual reading at -$3.9 million for FY2025, 88.72% up from the prior year.
  • Net Cash Flow was $1.2 million for Q4 2025 at Caribou Biosciences, up from -$14.1 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $305.8 million in Q3 2021 and troughed at -$194.9 million in Q4 2021.
  • The 5-year median for Net Cash Flow is -$8.7 million (2024), against an average of -$177350.0.
  • The largest YoY upside for Net Cash Flow was 3662.69% in 2021 against a maximum downside of 2167.74% in 2021.
  • A 5-year view of Net Cash Flow shows it stood at -$194.9 million in 2021, then soared by 87.82% to -$23.7 million in 2022, then crashed by 122.75% to -$52.9 million in 2023, then skyrocketed by 70.36% to -$15.7 million in 2024, then skyrocketed by 107.96% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Net Cash Flow are $1.2 million (Q4 2025), -$14.1 million (Q3 2025), and -$4.2 million (Q2 2025).